
Your flu shot was not useless. Here's what this season's numbers actually mean.
The 2025-26 flu vaccine was less effective than last season's estimate, but it still reduced flu-related visits and hospitalizations; here's what that means for Gen Z and what to do next season.
The headline number is lower, but it is not a fail
If you saw a headline saying this season's flu vaccine was only around 30% effective, the reasonable reaction is: so what was the point?
The point is that a flu vaccine is not a force field, and this season was a difficult test. A new version of the H3N2 flu virus became dominant after the vaccine strains had already been chosen. Even so, the available U.S. data found that vaccination lowered the odds of flu-related urgent care, emergency visits, and hospitalization. 1
Here is the useful version of the story for people in their late teens and 20s: the vaccine did not prevent every infection, but it still shifted the odds in your favor. And the numbers you are seeing are interim, not a final verdict on the vaccine or on next season's shot. 2
What the numbers actually say
CDC's U.S. estimates came from several surveillance networks that compared people who showed up for care with an acute respiratory illness. The researchers looked at who tested positive for flu and who tested negative, then adjusted for factors such as age, location, and timing. That is why vaccine effectiveness is best read as a relative reduction in risk, not as a promise that a certain percentage of vaccinated people will never get sick. 1
For the age range most relevant to Gen Z, the CDC table estimated:
- Adults ages 18–64: 36% effectiveness against an outpatient flu visit and 29% against hospitalization in the VISION network.
- All adults 18 and older: 22%–34% against outpatient visits, depending on the network, and 30% against hospitalization.
- Children and teens: 38%–41% against outpatient visits and 41% against hospitalization in the report's overall summary.
Those are not identical results because the networks used different settings, populations, and methods. Some smaller subgroup estimates were not statistically significant or were not reportable, which is another reason not to turn one number into a universal personal prediction. 2
A separate U.S. surveillance study using data through March 14, 2026 estimated 35% effectiveness against flu-related emergency-department or urgent-care visits and 27% against hospitalization. Its estimate is in the same general neighborhood as the CDC figures, which is more reassuring than a single viral number on social media. 3
Why this season was harder
The 2025–26 vaccine was designed to cover three main seasonal viruses: an H1N1 virus, an H3N2 virus, and a B/Victoria virus. After the vaccine strains were selected, an H3N2 subclade known as subclade K emerged and spread. CDC describes it as antigenically drifted, meaning its surface features were different enough from the vaccine's H3N2 component to make the immune match less tidy. 4
That explains why protection was uneven. In the CDC data, vaccine effectiveness against H3N2 outpatient illness among adults was much less convincing in some networks, while effectiveness against influenza B outpatient illness was 63% in the VISION adult analysis. For adults ages 18–64, the VISION estimate was 35% against influenza A outpatient illness and 66% against influenza B. 1
A later surveillance study found that 92.7% of characterized H3N2 viruses were subclade K and that post-vaccination antibody levels against it were reduced compared with the vaccine virus. That is a biological reason for lower protection, but it is not the same as zero protection. The same study still found a reduced risk of flu among vaccinated people. 3
The CDC's historical table puts the overall 2025–26 estimate at 36%, compared with 56% for 2024–25 and 44% for 2023–24. But the agency also labels the 2024–25 and 2025–26 figures preliminary, and different seasons have different viruses, timing, and study populations. This is a rough season-to-season comparison, not a scoreboard for whether vaccination "worked." 5
What this means for next flu season
The practical takeaway is not to wait for a perfect match. You cannot know in advance which flu viruses will dominate, and the vaccine can still lower the chance of medical visits and severe disease when a drifted virus is circulating. CDC continues to recommend annual flu vaccination for everyone 6 months and older who does not have a contraindication. 6
For most healthy adults in their 20s:
- Plan for September or October. CDC says vaccination should ideally be offered during those months for most people. If you miss that window, getting vaccinated later can still help while flu viruses are circulating.
- Take the age-appropriate option that is available. For most people under 65, CDC does not prefer one age-appropriate product over another when more than one is available. Your pharmacist or clinician can sort out exceptions based on pregnancy, immune status, allergies, or other medical conditions. 6
- Do not use this season's mismatch as a reason to skip the next shot. A mismatch can lower effectiveness; it does not make the vaccine useless. It also does not mean next season will have the same dominant virus.
- Use the rest of the prevention toolkit. If you are sick, stay home until your symptoms are improving overall and you have been fever-free for at least 24 hours without fever-reducing medicine. Cleaner indoor air, handwashing, covering coughs, and a well-fitting mask around sick people can add another layer. 7
If you still get flu after a shot
A vaccine does not rule out flu. Sudden fever or chills, cough, sore throat, body aches, headache, and heavy fatigue fit the usual pattern, although not everyone gets a fever. 8
For most otherwise healthy people with a mild case, home care means rest, fluids, and staying away from other people while you are most contagious. Do not start leftover antibiotics: flu is caused by a virus, and antibiotics do not treat it.
If you are pregnant, immunocompromised, or have conditions such as asthma, diabetes, or heart or lung disease, contact a health professional promptly when flu symptoms start. CDC recommends antiviral treatment as soon as possible for people at higher risk, people with severe or worsening illness, and people who are hospitalized. Antivirals work best when started within 48 hours, but later treatment can still help people with severe illness or a higher risk of complications. 9
Even if you are not in a high-risk group, contacting a clinician early can be reasonable if you have a strong flu-like illness and are still within the first two days, because treatment decisions are time-sensitive. Do not wait for a home test result if you are seriously ill.
When to get real help
Call 911 for trouble breathing, shortness of breath that is getting worse, persistent chest or abdominal pressure, new confusion, inability to wake normally, or a seizure.
Get urgent medical advice for not urinating, severe weakness or unsteadiness, severe muscle pain, or symptoms that improve and then come back worse. Those are not "just ride it out" signs. 8
The honest bottom line: this season's flu shot was less effective than last season's estimate, partly because a drifted H3N2 virus took over. But a vaccine that cuts risk by roughly a quarter to a third, and can still reduce severe outcomes, is not a failed vaccine. It is one useful layer. Add early treatment when it is appropriate, stay home when you are sick, and make the next shot a calendar task rather than a referendum on one rough flu season.
참고 출처
- 1Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — CDC
- 2Preliminary Flu Vaccine Effectiveness Data for 2025–2026 — CDC
- 3Influenza Activity and Estimated Vaccine Effectiveness During the 2025–2026 Influenza Season — PubMed
- 42025–2026 Flu Season — CDC
- 5Past Seasons' Vaccine Effectiveness Estimates — CDC
- 6ACIP Recommendations Summary — CDC
- 7Preventing Seasonal Flu — CDC
- 8Signs and Symptoms of Flu — CDC
- 9Influenza Antiviral Medications: Summary for Clinicians — CDC
관련 콘텐츠
- 로그인하면 댓글을 작성할 수 있습니다.
More from this channel›
- Costa Rica just got a chikungunya travel alert. Here's the bite-and-vaccine plan.
- The Cyclospora outbreak now has a food link. Here's the Taco Bell reality check.
- Ebola is spreading fast in the DRC. Here's the travel reality check.
- A parasite outbreak is driving a lot of summer diarrhea. Here's the Cyclospora plan.
- Your nosebleed is not a head-tilt moment. Here's the stop-the-bleed plan.
- Your allergy pill can still make you sleepy. Here's the antihistamine plan.
- Your Q-tip is not an ear-cleaning tool. Here's the earwax plan.
- Your back-seat nausea is not random. Here's the motion-sickness plan.
